 For Appointments
617-726-8748
Fax
617-724-3166
Office Address
Massachusetts General Hospital Cancer Center
Center for Sarcoma and Connective Tissue Oncology
55 Fruit Street, YAW 7
Boston, MA 02114
Clinical Interests
Sarcoma; Lymphoma of Bone; Multiple Myeloma; Immune Cytopenias; General Hematology
Education
MD Degree: Harvard Medical School, 1974
Postdoctoral Training
Residency: Rhode Island Hospital, Providence, RI
Fellowship: Hematology & Oncology, Massachusetts General Hospital, Boston, MA
Board Certification
Internal Medicine, 1978
Hematology, 1980
Academic Appointments
Assistant Professor, Harvard Medical School
My Publications
Link to PubMed Database
Selected Publications
Kraybill WG, Harris J, Spiro IJ, Ettinger DS, DeLaney TF, Blum RH, Lucas DR, Harmon DC, Letson GD, Eisenberg B; Radiation Therapy Oncology Group Trial 9514. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol. 2006 Feb 1;24(4):619-25.
Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC, Gebhardt MC. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res. 2004 Dec;(429):286-91.
DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, Harmon DC. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1117-27.
Fidias P, Spiro I, Sobczak ML, Nielsen GP, Ruffolo EF, Mankin H, Suit HD, Harmon DC. Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1213-8.
| 
